451 results on '"Zhang, Kerang"'
Search Results
2. A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder
3. Characteristics of gut microbiota and its correlation with hs-CRP and somatic symptoms in first-episode treatment-naive major depressive disorder
4. Latent classes of symptom trajectories among major depressive disorder patients in China
5. SE-1DCNN-LSTM: A Deep Learning Framework for EEG-Based Automatic Diagnosis of Major Depressive Disorder and Bipolar Disorder
6. Proinflammatory phenotype in major depressive disorder with adulthood adversity: In line with social signal transduction theory of depression
7. Immunoregulatory role of the gut microbiota in inflammatory depression
8. Cortical activation for adolescent-onset minor depression and major depressive disorder: an fNIRS study
9. Association analysis of gut microbiota and efficacy of SSRIs antidepressants in patients with major depressive disorder
10. Childhood adversity, adulthood adversity and suicidal ideation in Chinese patients with major depressive disorder: in line with stress sensitization
11. SE-1DCNN-LSTM: A Deep Learning Framework for EEG-Based Automatic Diagnosis of Major Depressive Disorder and Bipolar Disorder
12. Distinguishing between bipolar depression and unipolar depression based on the reward circuit activities and clinical characteristics: A machine learning analysis
13. EEG microstates as markers of major depressive disorder and predictors of response to SSRIs therapy
14. Major depressive disorder comorbid with general anxiety disorder: Associations among neuroticism, adult stress, and the inflammatory index
15. Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
16. Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder
17. The effect of selective serotonin reuptake inhibitors on cognitive impairment in patients with depression: A prospective, multicenter, observational study
18. Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment
19. Neurocognitive profiles of patients with first-episode and recurrent depression: a cross-sectional comparative study from China
20. Research on Cognitive Function in Anxious Depression Patients in China
21. Demographic and Psychosocial Variables Could Predict the Occurrence of Major Depressive Disorder, but Not the Severity of Depression in Patients with First-episode Major Depressive Disorder in China
22. Functional connectivity of the prefrontal cortex and amygdala is related to depression status in major depressive disorder
23. Severe sleep disturbance is associated with executive function impairment in patients with first-episode, treatment-naïve major depressive disorders
24. Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: A cross-sectional study
25. Perceived stressfulness mediates the effects of subjective social support and negative coping style on suicide risk in Chinese patients with major depressive disorder
26. The effect of short-term use of benzodiazepines on cognitive function of major depressive disorder patients being treated with antidepressants
27. Molecular Signatures of Major Depression
28. Gut microbiota characteristics and its immunoregulatory role in inflammatory depression: joint clinical and animal data
29. Abnormal cortical-striatal-thalamic-cortical circuit centered on the thalamus in MDD patients with somatic symptoms: Evidence from the REST-meta-MDD project
30. Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls
31. The interaction of combined effects of the BDNF and PRKCG genes and negative life events in major depressive disorder
32. PTPRR regulates ERK dephosphorylation in depression mice model
33. A co-expression network analysis reveals lncRNA abnormalities in peripheral blood in early-onset schizophrenia
34. Clinical features of and risk factors for major depression with history of postpartum episodes in Han Chinese women: A retrospective study
35. Identify abnormalities in resting-state brain function between first-episode, drug-naive major depressive disorder and remitted individuals: a 3-year retrospective study
36. A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Verify the Efficacy and Safety of Ansofaxine (LY03005) for Major Depressive Disorder
37. Influence of childhood maltreatment on major depressive disorder in adulthood: mediating role of social support
38. Theta oscillations: A rhythm difference comparison between major depressive disorder and anxiety disorder
39. A combined study of GSK3β polymorphisms and brain network topological metrics in major depressive disorder
40. Features of cognitive impairment and related risk factors in patients with major depressive disorder: A case-control study
41. Abnormal gut microbiota and bile acids in patients with first‐episode major depressive disorder and correlation analysis
42. P182. Diagnostic Classification of Schizophrenia and Bipolar Disorders Using Machine Learning on Resting-State EEG
43. P317. Differentiating Major Depression With and Without Psychotic Symptoms Based on Resting-State EEG
44. Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial
45. Altered Cingulum Functioning in Major Depressive Disorder Patient With Suicide Attempts: A Resting-State Functional Magnetic Resonance Imaging Study
46. Co-Expression Network Modeling Identifies Specific Inflammation and Neurological Disease-Related Genes mRNA Modules in Mood Disorder
47. Cortical Thickness Predicts Response Following 2 Weeks of SSRI Regimen in First-Episode, Drug-Naive Major Depressive Disorder: An MRI Study
48. Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
49. Exploring the potential of thyroid hormones to predict clinical improvements in depressive patients: A machine learning analysis of the real-world based study.
50. Continuous GSK-3β overexpression in the hippocampal dentate gyrus induces prodepressant-like effects and increases sensitivity to chronic mild stress in mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.